The 3 best healthcare companies to buy today

How do Cochlear Limited (ASX:COH) and Ramsay Health Care Limited (ASX:RHC) REALLY stack up?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

So you're ready to crush the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) by buying healthcare companies.

Great choice!

There are some fantastic, globally diversified companies which make up the S&P/ASX 200 Health Care Index (Index: ASX: XHJ), many of which churn out huge returns. But where should you start?

A valuable metric to look at here is return on equity (ROE). Return on equity reflects the return a company generates on funding provided by investors. A high return on equity can provide the means to invest back into the company for years, or to return funds to investors via dividends or share buy-backs.

By an absolute mile, the two standouts from the Health Care Index are CSL Limited (ASX: CSL) and Cochlear Limited (ASX: COH), with returns on equity of 50% and 41% respectively. Both companies have strong proprietary product lines and naturally growing demand to support earnings going forward. Here is how they compare to some of the other big name ASX healthcare companies:

Net Income ($millions) Total equity ($millions) ROE Debt/equity
CSL Limited (US$) 1,379 2,747 50% 1.3
Cochlear Limited 147 355 41% 1.4
Sirtex Medical Limited 40 145 28% 0.4
Fisher & Paykel Healthcare Corp Ltd 113 471 24% 0.4
Ramsay Health Care Limited 419 1,833 23% 3.1
ResMed Inc. 353 1,587 22% 0.4
Ansell Limited 189 1,166 16% 1

Source: company 2015 annual reports

Both CSL and Cochlear also have what I view as appropriate debt levels given the returns they are making, and the sustainability of these returns, make servicing their debt manageable.

This is really important since one way companies can jack up their return on equity is by funding operations with more debt and less equity. Ramsay Health Care Limited (ASX: RHC) for example has a big pile of debt equivalent to over 3x the company's equity. This is not necessarily bad, especially given Ramsay's strong projected growth over the coming years, but it does increase risk.

Of the remaining companies listed above, my pick would be ResMed Inc. (CHESS) (ASX: RMD). ResMed has an attractive, boring quality which I like. Although the company has a lower ROE than both Sirtex Medical Limited (ASX: SRX) and Fisher & Paykel Healthcare Corp Ltd (ASX: FPH), I currently prefer ResMed's valuation to that of Fisher & Paykel Healthcare and prefer ResMed's lower risk profile to that of Sirtex.

Motley Fool contributor Regan Pearson has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »